scPharmaceuticals Inc. (SCPH) Misses Q1 EPS by 4c

scPharmaceuticals Inc. (NASDAQ: SCPH) reported Q1 EPS of ($0.36), $0.04 worse than the analyst estimate of ($0.32). Revenue for the quarter came in at $11.8 million versus the consensus estimate of $12.83 million.

For earnings history and earnings-related data on scPharmaceuticals Inc. (SCPH) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Alphabet (GOOGL) call put ratio 1.6 calls to 1 put with a focus on June 22 weekly calls as share price down 6%
• OpenAI launches open-source security program with Trail of Bits